-
NIH Aug 13, 2019 | R21
Developing Clinical Translational Tools to Communicate Genetic Risk to Individuals who are at Clinical High Risk for Psychosis
Institution: NEW YORK UNIVERSITY
FOA Number: PA-18-344
Abstract
While great strides are being made in identifying early signs that place people at a ?high risk state? for different illness conditions, at the same time, advances are being made in the identification of genes associated with ?high-risk states?. This study proposes to develop two innovative clinical tools that could greatly facilitate dissemination of a beneficial genetic malleability framing to high-risk youth in order to encourage increased treatment engagement and uptake of healthy behaviors. The impact of genetic information assumes special importance in the ?high-risk state? because achieving the best possible outcome is more likely if individuals actively choose to engage in beneficial treatment and health-promoting behaviors.
FUNDING AGENCY:
Funder:
NIHInstitute:
NATIONAL HUMAN GENOME RESEARCH INSTITUTEFunding Type:
R21Project Number:
R21HG010420Start Date:
Aug 13, 2019End Date:
Jul 31, 2021PROJECT TERMS:
Abbreviations, Address, Age, Attenuated, base, Behavior, Behavioral, behavioral outcome, Belief, brca gene, Breast Cancer gene, Breast Cancer Risk Factor, Clinical, computerized, Computers, Control Groups, design, Development, Diabetes Mellitus, Diagnosis, Disease, Distant, Early Intervention, Effectiveness, efficacy testing, essentialism, Exposure to, Future, Gene Expression, Genes, Genetic, Genetic Determinism, genetic discrimination, genetic information, Genetic Risk, Goals, Health, Health Promotion, high risk, improved, improved outcome, Individual, innovation, Link, Literature, malleable risk, Manuals, modifiable risk, National Human Genome Research Institute, non-genetic, Outcome, Participant, prevent, Preventive, primary outcome, protective behavior, psychogenetics, Psychotic Disorders, Public Health, Randomized Clinical Trials, Research, response, Risk, Risk Behaviors, Risk Factors, risk variant, Safety, Sampling, secondary outcome, Self Management, social stigma, Stress, Testing, Time, tool, Training, uptake, Work, young adult, Youth